PVLA · Company research
Palvella Therapeutics, Inc. Common Stock (PVLA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| (PVLA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily | (PVLA) as a Liquidity Pulse for Institutional Tactics Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 17, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 16, 2026 | neutral | 0 | 0.6 |
| Children with two rare skin conditions showed less severe disease in new analyses - Stock Titan | Children with two rare skin conditions showed less severe disease in new analyses Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Palvella Therapeutics director George M. Jenkins disposes of $3.58m PVLA stock - Investing.com | Palvella Therapeutics director George M. Jenkins disposes of $3.58m PVLA stock Investing.com | View source ↗ | Investing.com | Oct 14, 2026 | neutral | 0 | 0.6 |
| Under a trading plan, George M. Jenkins sold 27,500 shares of Palvella Therapeutics (PVLA). - Stock Titan | Under a trading plan, George M. Jenkins sold 27,500 shares of Palvella Therapeutics (PVLA). Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Palvella Therapeutics (PVLA) and Mineralys Therapeutics, Inc. (MLYS) - The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Palvella Therapeutics (PVLA) and Mineralys Therapeutics, Inc. (MLYS) The Globe and Mail | View source ↗ | The Globe and Mail | Oct 13, 2026 | neutral | 0 | 0.6 |
| Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Palvella Therapeutics (PVLA) and Mineralys Therapeutics, Inc. (MLYS) - The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Palvella Therapeutics (PVLA) and Mineralys Therapeutics, Inc. (MLYS) The Globe and Mail | View source ↗ | The Globe and Mail | Oct 13, 2026 | neutral | 0 | 0.6 |
| Palvella posters estimate 154,986 U.S. DSAP patients | PVLA Stock News - Stock Titan | Palvella posters estimate 154,986 U.S. DSAP patients | PVLA Stock News Stock Titan | View source ↗ | Stock Titan | Oct 12, 2026 | neutral | 0 | 0.6 |
| PVLA Oct 2026 155.000 call (PVLA261016C00155000) Stock Price, News, Quote & History - Yahoo! Finance Canada | PVLA Oct 2026 155.000 call (PVLA261016C00155000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 12, 2026 | neutral | 0 | 0.6 |
| PVLA Feb 2027 105.000 call (PVLA270219C00105000) Interactive Stock Chart - Yahoo Finance - Yahoo! Finance Canada | PVLA Feb 2027 105.000 call (PVLA270219C00105000) Interactive Stock Chart - Yahoo Finance Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 12, 2026 | neutral | 0 | 0.6 |
| PVLA Oct 2026 145.000 put (PVLA261016P00145000) Stock Historical Prices & Data - Yahoo! Finance Canada | PVLA Oct 2026 145.000 put (PVLA261016P00145000) Stock Historical Prices & Data Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 8, 2026 | neutral | 0 | 0.6 |
| Price-Driven Insight from (PVLA) for Rule-Based Strategy - Stock Traders Daily | Price-Driven Insight from (PVLA) for Rule-Based Strategy Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| Palvella Therapeutics Inc (PVLA-Q) Stock Price and News - The Globe and Mail | Palvella Therapeutics Inc (PVLA-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 2, 2026 | neutral | 0 | 0.6 |
| Palvella Therapeutics: FDA Handholding Makes The Regulatory Story Stronger (NASDAQ:PVLA) - Seeking Alpha | Palvella Therapeutics: FDA Handholding Makes The Regulatory Story Stronger (NASDAQ:PVLA) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 29, 2026 | neutral | 0 | 0.6 |
| A potential treatment for an estimated 30,000-plus U.S. patients could launch in 2027, if approved - Stock Titan | A potential treatment for an estimated 30,000-plus U.S. patients could launch in 2027, if approved Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Palvella Therapeutics (PVLA) COO sells 4,302 shares under 10b5-1 plan - Stock Titan | Palvella Therapeutics (PVLA) COO sells 4,302 shares under 10b5-1 plan Stock Titan | View source ↗ | Stock Titan | Sep 18, 2026 | neutral | 0 | 0.6 |
| Director at Palvella Therapeutics (PVLA) sells 27,500 shares under trading plan - Stock Titan | Director at Palvella Therapeutics (PVLA) sells 27,500 shares under trading plan Stock Titan | View source ↗ | Stock Titan | Sep 15, 2026 | neutral | 0 | 0.6 |
| $PVLA stock is down 10% today. Here's what we see in our data. - Quiver Quantitative | $PVLA stock is down 10% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 20, 2026 | neutral | 0 | 0.6 |
| Palvella Therapeutics (PVLA) Stock Valuation Check After Strong Recent Momentum - Yahoo Finance | Palvella Therapeutics (PVLA) Stock Valuation Check After Strong Recent Momentum Yahoo Finance | View source ↗ | Yahoo Finance | Jun 15, 2026 | neutral | 0 | 0.6 |
| PVLA Stock Soars On Strong Phase 3 Results For Rare Vascular Disorder Treatment - Stocktwits | PVLA Stock Soars On Strong Phase 3 Results For Rare Vascular Disorder Treatment Stocktwits | View source ↗ | Stocktwits | Mar 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.